SIRT1 is reduced by growth factors in human pulmonary artery smooth muscle cells in vitro and in a monocrotaline-induced pulmonary hypertension in rats, whereas SIRT1 inhibits smooth muscle proliferation (Zhou et al, 2015). Here, SIRT1 is linked to pulmonary hypertension.